Identification of serum biomarkers for premature ovarian failure

被引:13
|
作者
Lee, Da-Hye [1 ]
Pei, Chang-Zhu [1 ]
Song, Jae-Yun [2 ]
Lee, Kyung-Ju [2 ]
Yun, Bo-Seong [3 ]
Kwack, Kyu-Bum [1 ]
Lee, Eun-Il [4 ]
Baek, Kwang-Hyun [1 ]
机构
[1] CHA Univ, Dept Biomed Sci, 335 Pangyo Ro, Seongnam Si 13488, Gyeonggi Do, South Korea
[2] Korea Univ, Anam Hosp, Coll Med, Dept Obstet & Gynecol, Seoul 02841, South Korea
[3] CHA Univ, Gangnam CHA Hosp, Coll Med, Dept Obstet & Gynecol, Seoul 06135, South Korea
[4] Korea Univ, Coll Med, Dept Prevent Med, Seoul 02841, South Korea
来源
关键词
Biomarker; Early menopause; MALDI-TOF; Serum; Two-dimensional electrophoresis; WOMENS HEALTH; HORMONE; COPPER; GENE; FIBRINOLYSIS; COAGULATION; COMPLEMENT; PROTEINS; MARKERS;
D O I
10.1016/j.bbapap.2018.12.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Premature ovarian failure (POP) is defined when a female achieves menopause before the age of 40. Although many conditions are known to be causative for POF, the most common one is idiopathic. This study was undertaken to investigate the pathogenesis of POF using proteomic tools. Two-dimensional electrophoresis (2-DE) analysis was performed to screen for proteins differentially expressed in patients with POF. Using liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS), we identified 11 significant proteins differentially expressed in the serum of POF patients: 5 proteins with expression increased more than two folds, 5 proteins with expression decreased more than two folds, and 1 protein expressed specifically in the serum of patients with POF. The results of the 2-DE analysis were further validated by Western blotting and ELISA analyses, which 5 reproductive system-related proteins (Ceruloplasmin, Complement C3, Fibrinogen alpha, Fibrinogen beta, and SHBG) were selected. The different expression levels for these proteins were confirmed and demonstrated the possibility of using them as biomarkers to screen POF. These pre-clinical data provide plausible translational implications for targeting the pathogenesis of POF for each protein.
引用
收藏
页码:219 / 226
页数:8
相关论文
共 50 条
  • [11] Premature ovarian failure
    Callejo, Justo
    Hernandez, Agustin
    Valladares, Esther
    Lailla, Josep M.
    GINECOLOGIA Y OBSTETRICIA CLINICA, 2008, 9 (01): : 15 - 24
  • [12] Premature ovarian failure
    Meskhi, Apollo
    Seif, Mourad W.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2006, 18 (04) : 418 - 426
  • [13] Premature ovarian failure
    Sinha, P.
    Kuruba, N.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2007, 27 (01) : 16 - 19
  • [14] Premature ovarian failure
    Chiauzzi, Violeta
    Sundblad, Victoria
    Ferder, Ianina
    Dain, Liliana
    Charreau, Eduardo
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2011, 45 (04): : 623 - 625
  • [15] PREMATURE OVARIAN FAILURE
    MARKWOOD, R
    MAGYAR, D
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 1985, 85 (04): : 259 - 263
  • [16] Premature ovarian failure
    Shelling, Andrew N.
    REPRODUCTION, 2010, 140 (05) : 633 - 641
  • [17] PREMATURE OVARIAN FAILURE
    STARUP, J
    SELE, V
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1973, 52 (03) : 259 - 268
  • [18] Premature ovarian failure
    Falsetti, L
    Scalchi, S
    Villani, MT
    Bugari, G
    GYNECOLOGICAL ENDOCRINOLOGY, 1999, 13 (03) : 189 - 195
  • [19] Premature ovarian failure
    Maclaran, Kate
    Panay, Nick
    JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2011, 37 (01): : 35 - 42
  • [20] Premature ovarian failure
    Paolo Beck-Peccoz
    Luca Persani
    Orphanet Journal of Rare Diseases, 1